Andrew Leonard Laccetti, Matthew R Smith, Howard I. Scher, Sepehr Nowfar, David Johnson Einstein, Benjamin Martin, Patrick Adorjan, Manjari Dissanayake, Frank Verholen, Xin Gao. "Darolutamide monotherapy in patients with castration-sensitive prostate cancer (CSPC) after biochemical recurrence (BCR): ARAMON lead-in phase results.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.150